Georgia Keresty Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Georgia Keresty is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 23,883 shares of NTLA, which is worth approximately $341,526. The most recent transaction as insider was on Jun 12, 2024, when has been sold 7,737 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K
0% 3M change
47.92% 12M change
Total Value Held $341,526

Georgia Keresty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
7,737 Added 24.47%
23,883 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
4,425 Added 21.51%
16,146 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
5,197 Added 30.72%
11,721 Common Stock
Jun 23 2021
BUY
Grant, award, or other acquisition
-
2,094 Added 50.0%
2,094 Common Stock
Apr 09 2021
BUY
Grant, award, or other acquisition
-
4,955 Added 50.0%
4,955 Common Stock

Also insider at

SLDB
Solid Biosciences Inc. Healthcare
GK

Georgia Keresty

Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA